Cerus Corporation

CERS ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-60.6M $-62.9M $-55.9M $-38.8M $-43.3M $-15.9M $-17.0M $-16.9M
Depreciation & Amortization $1.8M $1.8M $1.7M $1.4M $745.0K $744.0K $922.0K $853.0K
Depreciation — — — — — — — —
Amortization $202.0K $202.0K $202.0K $202.0K $202.0K $202.0K $202.0K $67.0K
Stock-Based Compensation $9.4M $8.1M $6.7M $5.2M $3.3M $2.5M $1.9M $1.8M
Net Cash from Operating Activities $-52.2M $-53.5M $-51.1M $-39.8M $-26.8M $-13.9M $-15.6M $-14.3M
Investing Activities
Capital Expenditures $353.0K $563.0K $722.0K $2.1M $663.0K $81.0K $158.0K $1.7M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $421.0K $-19.9M — — $-29.1M $205.0K $563.0K $-70.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $43.0M $24.6M — — $58.6M $14.9M $11.6M $26.0M
Net Change in Cash $-8.8M $-48.9M $48.2M $-6.7M $2.8M $1.2M $-3.5M $11.7M
Free Cash Flow $-52.6M $-54.1M $-51.9M $-41.9M $-27.5M $-14.0M $-15.8M $-16.0M
← Newer Page 2 of 3 Older →